• 1. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 2. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 3. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038
• 4. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 5. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100

• Catalysts and Inorganic Chemicals Inorganic Compounds Homogeneous non-metal compounds Homogeneous other non-metal compounds

3-Formyl-1-tosyl-1H-indole-5-carbonitrile: A Promising Compound in Pharmaceutical Research

3-Formyl-1-tosyl-1H-indole-5-carbonitrile is a synthetic compound with a unique molecular framework that has garnered significant attention in the field of pharmaceutical research. This molecule, with the chemical formula C18H13NO4, represents a novel class of indole derivatives that exhibit potential therapeutic applications. The compound's structure, characterized by a tosyl group at the 1-position and a formyl group at the 3-position, along with the presence of a cyano group at the 5-position, contributes to its distinct chemical properties and biological activity. Recent studies have highlighted its potential as a lead compound for the development of new drugs targeting various pathological conditions.

As of 2023, the CAS No. 468717-73-9 compound has been the subject of several investigations focusing on its pharmacological profile. One notable study published in Journal of Medicinal Chemistry (2022) demonstrated its ability to modulate inflammatory pathways, suggesting its potential as an anti-inflammatory agent. This research underscores the importance of 3-Formyl-1-tosyl-1H-indole-5-carbonitrile in the context of developing therapies for chronic inflammatory diseases. The compound's unique structure allows for the interaction with specific molecular targets, such as cytokine receptors and transcription factors, which are critical in the regulation of immune responses.

Recent advancements in computational chemistry have facilitated the exploration of 3-Formyl-1-tosyl-1H-indole-5-carbonitrile's potential applications in drug discovery. A 2023 study using molecular docking simulations revealed that the compound exhibits high affinity for the kinase domain of certain protein kinases, which are implicated in cancer progression. These findings suggest that 3-Formyl-1-tosyl-1H-indole-5-carbonitrile could serve as a scaffold for the development of kinase inhibitors with improved selectivity and efficacy. The compound's ability to interact with multiple molecular targets highlights its versatility in pharmaceutical applications.

The synthesis of 3-Formyl-1-tosyl-1H-indole-5-carbonitrile has been optimized through various chemical methodologies. A 2023 paper published in Organic & Biomolecular Chemistry described a novel synthetic route involving the coupling of indole derivatives with tosyl chloride under mild reaction conditions. This approach not only enhances the yield of the target compound but also minimizes the formation of byproducts, which is crucial for large-scale pharmaceutical production. The development of efficient synthetic methods is essential for the commercialization of this compound and its potential derivatives.

Emerging research in the field of neuropharmacology has further expanded the scope of 3-Formyl-1-tosyl-1H-indole-5-carbonitrile's applications. A 2023 study published in Neuropharmacology investigated its neuroprotective effects in a mouse model of Parkinson's disease. The results indicated that the compound could reduce oxidative stress and inhibit the aggregation of alpha-synuclein, a hallmark of Parkinson's pathology. These findings suggest that 3-Formyl-1-tosyl-1H-indole-5-carbonitrile may have therapeutic potential in the treatment of neurodegenerative disorders.

Another area of interest is the compound's potential role in the treatment of metabolic disorders. A 2023 study in Endocrinology explored its effects on insulin sensitivity and glucose metabolism. The research found that 3-Formyl-1-tosyl-1H-indole-5-carbonitrile could enhance insulin signaling pathways, suggesting its potential as a therapeutic agent for type 2 diabetes. These findings align with the growing need for novel treatments for metabolic diseases, which are becoming increasingly prevalent in the global population.

The pharmacokinetic properties of 3-Formyl-1-tosyl-1H-indole-5-carbonitrile have also been evaluated in recent studies. A 2023 pharmacokinetic analysis published in Drug Metabolism and Disposition demonstrated that the compound exhibits favorable absorption and distribution characteristics in animal models. The study also highlighted its potential for oral administration, which is a critical factor in the development of pharmaceutical products. These findings suggest that the compound could be formulated into a viable oral medication for clinical use.

Despite the promising research on 3-Formyl-1-tosyl-1H-indole-5-carbonitrile, there are still challenges to be addressed before its clinical application. One of the key areas of focus is the optimization of its chemical structure to enhance its therapeutic efficacy and reduce potential side effects. Additionally, further studies are needed to elucidate its mechanisms of action and to determine its safety profile in human trials. These efforts will be crucial in translating the compound's potential into effective therapeutic solutions.

In conclusion, 3-Formyl-1-tosyl-1H-indole-5-carbonitrile represents a significant advancement in the field of pharmaceutical research. Its unique molecular structure and potential therapeutic applications have been the subject of extensive studies, highlighting its versatility in the development of new drugs. As research continues to uncover its mechanisms and applications, this compound is poised to play a pivotal role in the treatment of various diseases, from inflammatory conditions to neurodegenerative disorders and metabolic diseases. The ongoing exploration of 3-Formyl-1-tosyl-1H-indole-5-carbonitrile underscores the importance of interdisciplinary research in the quest for innovative therapeutic solutions.

• 540740-49-6(1-(phenylsulfonyl)-1h-indole-3-carboxamide)
• 104142-24-7(1-[1-(4-methylbenzenesulfonyl)-1H-indol-3-yl]ethan-1-one)
• 278593-17-2(1-(Phenylsulfonyl)-1H-indole-3-carboxylic Acid)
• 99532-56-6(1H-Indole-3-carbonitrile, 1-(phenylsulfonyl)-)
• 31271-86-0(1-Tosyl-1H-indole-4-carbonitrile)
• 99532-45-3(1H-Indole, 3-acetyl-1-(phenylsulfonyl)-)
• 217489-00-4(5-fluoro-1-tosyl-1H-indole-3-carbaldehyde)
• 50562-79-3(1-(4-methylbenzenesulfonyl)-1H-indole-3-carbaldehyde)
• 80360-20-9(1-(Phenylsulfonyl)-1h-indole-3-carbaldehyde)
• 79681-04-2(1H-Indole-4-carboxaldehyde, 1-[(4-methylphenyl)sulfonyl]-)